Among medical mutual funds, the Vanguard Health Care Fund stands out for performance, low expenses, and its managers' buy-and-hold philosophy. But don't buy it just for the yield -- its high dividend is an illusion.
Looking for Big Pharma bargains? Mallinckrodt, Bayer, and Bristol-Myers Squibb might be right up your alley.
A look at the past, present, and future to determine which big pharma is the best dividend stock of them all.
Let Pfizer be Pfizer? Staying one company could be a bad move for shareholders.
Regeneron Pharmaceuticals stock is far more expensive than its peers. Here's why.
These big pharma stocks have done well for investors lately, but which is the smarter pick now?
If you're looking for cheap dividend stocks, these three names should be on your radar.
Short-term disappointments have tossed these three stand-out stocks on the discount rack.
These three dividend aristocrats are either yielding a ton, growing a ton, or both!
Let's look at the challenges and opportunities facing these Big Pharma stocks to see which is most attractive now.